Dépistage sur goutte de sang séché : Questions médicales fréquentes
Nom anglais: Dried Blood Spot Testing
Descriptor UI:D059788
Tree Number:E05.200.124.100.232
Termes MeSH sélectionnés :
Multicenter Studies as Topic
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Dépistage sur goutte de sang séché : Questions médicales les plus fréquentes",
"headline": "Dépistage sur goutte de sang séché : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Dépistage sur goutte de sang séché : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-12",
"dateModified": "2025-03-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Dépistage sur goutte de sang séché"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Analyse chimique du sang",
"url": "https://questionsmedicales.fr/mesh/D001774",
"about": {
"@type": "MedicalCondition",
"name": "Analyse chimique du sang",
"code": {
"@type": "MedicalCode",
"code": "D001774",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.124.100"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Dépistage sur goutte de sang séché",
"alternateName": "Dried Blood Spot Testing",
"code": {
"@type": "MedicalCode",
"code": "D059788",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Stefan Gaugler",
"url": "https://questionsmedicales.fr/author/Stefan%20Gaugler",
"affiliation": {
"@type": "Organization",
"name": "CAMAG, Sonnenmattstrasse 11, Muttenz, Switzerland."
}
},
{
"@type": "Person",
"name": "Mario Thevis",
"url": "https://questionsmedicales.fr/author/Mario%20Thevis",
"affiliation": {
"@type": "Organization",
"name": "Center for Preventive Doping Research/Institute of Biochemistry, German Sport University Cologne, Cologne, Germany."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Tiia Kuuranne",
"url": "https://questionsmedicales.fr/author/Tiia%20Kuuranne",
"affiliation": {
"@type": "Organization",
"name": "Swiss Laboratory for Doping Analyses, University Center of Legal Medicine, Lausanne and Geneva, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland."
}
},
{
"@type": "Person",
"name": "Marc Luginbühl",
"url": "https://questionsmedicales.fr/author/Marc%20Luginb%C3%BChl",
"affiliation": {
"@type": "Organization",
"name": "CAMAG DBS Laboratory, Muttenz, Switzerland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Extended-spectrum beta-lactamase-producing Enterobacteriaceae related urinary tract infection in adult cancer patients: a multicenter retrospective study, 2015-2019.",
"datePublished": "2023-03-06",
"url": "https://questionsmedicales.fr/article/36879210",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12879-023-08023-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Simplified Clinical Prediction Rule for Prognosticating Dependent Daily Living in Patients with Thoracic Spinal Cord Injury: A Multicenter Nationwide Japan Registry Study.",
"datePublished": "2023-03-03",
"url": "https://questionsmedicales.fr/article/36871549",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000529780"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects.",
"datePublished": "2023-02-28",
"url": "https://questionsmedicales.fr/article/36880014",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2147/CPAA.S397826"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intraoperative complication of radical cystectomy for muscle-invasive bladder cancer: does the surgical approach matter? A retrospective multicenter study using the EAUiaiC classification.",
"datePublished": "2023-02-27",
"url": "https://questionsmedicales.fr/article/36847814",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00345-023-04340-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Artificial intelligence-based computer-aided diagnosis system supports diagnosis of lymph node metastasis in esophageal squamous cell carcinoma: A multicenter study.",
"datePublished": "2023-02-25",
"url": "https://questionsmedicales.fr/article/36923854",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.heliyon.2023.e14030"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Techniques d'investigation",
"item": "https://questionsmedicales.fr/mesh/D008919"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques de laboratoire clinique",
"item": "https://questionsmedicales.fr/mesh/D019411"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tests de chimie clinique",
"item": "https://questionsmedicales.fr/mesh/D019963"
},
{
"@type": "ListItem",
"position": 5,
"name": "Analyse chimique du sang",
"item": "https://questionsmedicales.fr/mesh/D001774"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dépistage sur goutte de sang séché",
"item": "https://questionsmedicales.fr/mesh/D059788"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Dépistage sur goutte de sang séché - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Dépistage sur goutte de sang séché",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Dépistage sur goutte de sang séché",
"description": "Quelles maladies peuvent être dépistées ?\nComment se déroule le test ?\nQuelle est la précision du test ?\nQuel est le délai pour obtenir les résultats ?\nLe test nécessite-t-il une préparation préalable ?",
"url": "https://questionsmedicales.fr/mesh/D059788?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Dépistage sur goutte de sang séché",
"description": "Quels symptômes indiquent un dépistage nécessaire ?\nLes symptômes varient selon la maladie ?\nLes nouveau-nés présentent-ils des symptômes ?\nComment les symptômes évoluent-ils ?\nPeut-on prévenir les symptômes par le dépistage ?",
"url": "https://questionsmedicales.fr/mesh/D059788?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Dépistage sur goutte de sang séché",
"description": "Comment prévenir les maladies dépistées ?\nLe dépistage néonatal est-il obligatoire ?\nLes vaccinations aident-elles à prévenir ?\nL'éducation des parents est-elle importante ?\nY a-t-il des programmes de sensibilisation ?",
"url": "https://questionsmedicales.fr/mesh/D059788?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Dépistage sur goutte de sang séché",
"description": "Quels traitements sont disponibles après un dépistage positif ?\nLe traitement est-il toujours nécessaire ?\nY a-t-il des effets secondaires aux traitements ?\nLe traitement est-il coûteux ?\nLe suivi est-il nécessaire après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D059788?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Dépistage sur goutte de sang séché",
"description": "Quelles complications peuvent survenir sans dépistage ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la vie ?\nLes complications varient-elles selon l'âge ?\nLe suivi peut-il réduire les complications ?",
"url": "https://questionsmedicales.fr/mesh/D059788?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Dépistage sur goutte de sang séché",
"description": "Quels sont les facteurs de risque pour les maladies dépistées ?\nL'alimentation influence-t-elle le risque ?\nLe mode de vie joue-t-il un rôle ?\nLes facteurs génétiques sont-ils importants ?\nLes infections peuvent-elles être un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D059788?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Quelles maladies peuvent être dépistées ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage peut identifier des maladies comme la phénylcétonurie, l'hypothyroïdie congénitale."
}
},
{
"@type": "Question",
"name": "Comment se déroule le test ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un échantillon de sang est prélevé sur un papier spécial et envoyé au laboratoire pour analyse."
}
},
{
"@type": "Question",
"name": "Quelle est la précision du test ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La précision dépend de la maladie, mais les tests sont généralement très fiables."
}
},
{
"@type": "Question",
"name": "Quel est le délai pour obtenir les résultats ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les résultats sont souvent disponibles en quelques jours à une semaine selon le laboratoire."
}
},
{
"@type": "Question",
"name": "Le test nécessite-t-il une préparation préalable ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucune préparation spéciale n'est requise avant le prélèvement de sang séché."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un dépistage nécessaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, la jaunisse ou des troubles de croissance peuvent alerter."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon la maladie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque maladie dépistée a ses propres symptômes spécifiques."
}
},
{
"@type": "Question",
"name": "Les nouveau-nés présentent-ils des symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent, les nouveau-nés n'ont pas de symptômes visibles, d'où l'importance du dépistage."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans traitement, les symptômes peuvent s'aggraver avec le temps, selon la maladie."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les symptômes par le dépistage ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un dépistage précoce permet d'initier un traitement avant l'apparition des symptômes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies dépistées ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut des dépistages réguliers et des conseils sur le mode de vie sain."
}
},
{
"@type": "Question",
"name": "Le dépistage néonatal est-il obligatoire ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans de nombreux pays, le dépistage néonatal est obligatoire pour détecter des maladies précoces."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent prévenir des maladies détectées par le dépistage."
}
},
{
"@type": "Question",
"name": "L'éducation des parents est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les parents sur les signes et l'importance du dépistage est crucial."
}
},
{
"@type": "Question",
"name": "Y a-t-il des programmes de sensibilisation ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux programmes visent à sensibiliser le public sur l'importance du dépistage."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles après un dépistage positif ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements varient selon la maladie, incluant des médicaments ou des régimes alimentaires."
}
},
{
"@type": "Question",
"name": "Le traitement est-il toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, cela dépend de la maladie et de sa gravité détectée par le dépistage."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains traitements peuvent avoir des effets secondaires, mais ils sont généralement gérables."
}
},
{
"@type": "Question",
"name": "Le traitement est-il coûteux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les coûts varient selon le traitement et le système de santé, mais des aides peuvent exister."
}
},
{
"@type": "Question",
"name": "Le suivi est-il nécessaire après traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour surveiller l'évolution de la maladie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans dépistage ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans dépistage, des complications graves peuvent survenir, comme des retards de développement."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement précoce, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent affecter la qualité de vie, l'éducation et l'intégration sociale des patients."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon l'âge ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent se manifester différemment selon l'âge du patient."
}
},
{
"@type": "Question",
"name": "Le suivi peut-il réduire les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier peut aider à détecter et à gérer les complications rapidement."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les maladies dépistées ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des conditions médicales et des facteurs environnementaux."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une mauvaise alimentation peut augmenter le risque de certaines maladies dépistées."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme ou l'inactivité physique augmentent les risques."
}
},
{
"@type": "Question",
"name": "Les facteurs génétiques sont-ils importants ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des prédispositions génétiques peuvent augmenter le risque de maladies spécifiques."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent augmenter le risque de maladies détectées par dépistage."
}
}
]
}
]
}
The aim of this study was to investigate the prevalence and risk factors of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae related urinary tract infections (UTI) in adult cancer ...
We conducted a retrospective study of three cancer hospitals centered on Cancer Hospital of Chinese Academy of Medical Sciences from 2015 to 2019. The clinical characters, risk factors and antimicrobi...
A total of 4967 specimens of UTI were evaluated, of which 909 were positive. After excluding multiple infection bacteria, non-conforming strains, inconsistent pathological information, no drug sensiti...
In view of the high prevalence, clinicians should be alert to the occurrence of ESBL UTI, especially for patients with urological cancer or metastatic tumors. Regular replacement of urinary catheters,...
Clinical prediction rule (CPR) using decision tree analysis is able to show the branching of the variables under consideration in a clear, hierarchical manner, including specific reference values, whi...
We extracted data on patients with thoracic SCI from a national multicenter registry database, the Japan Rehabilitation Database (JRD). All patients with thoracic SCI who were hospitalized within 30 d...
Three hundred ten patients with thoracic SCI were included in the CART analysis. The CART model identified, in a hierarchical order, patient's age, residual function level, and the bathing sub-score o...
We developed a simplified, moderately accurate CPR for predicting whether patients with thoracic SCI achieve independent living at hospital discharge....
Iberdomide, a novel cereblon modulator (CELMoD...
Forty subjects were enrolled in the study and divided into five groups based on hepatic function. 1 mg iberdomide was administered and plasma samples were collected to evaluate the pharmacokinetics of...
After a single dose of iberdomide (1 mg), mean iberdomide Cmax (maximum observed concentration) and AUC (area under the concentration-time curve) exposure were generally comparable between hepatic imp...
In summary, 1 mg single oral dose of iberdomide was generally well-tolerated. HI (mild, moderate or severe) had no clinically relevant impact on iberdomide PK and therefore, no dose adjustment is warr...
Despite surgical and anesthetic progress, radical cystectomy for bladder cancer remains one of the most morbid surgeries in urology. The objective of our study was to describe intraoperative complicat...
We retrospectively reviewed medical records of patients treated by radical cystectomy for localized muscle invasive bladder cancer between 2015 and 2020, following the Martin et al. criteria for compl...
A total of 318 patients were included for analysis. Among them, 17 patients (5.4%) presented an intraoperative complication. No preoperative oncological or clinical factor was associated with the occu...
Radical cystectomy remains a highly morbid surgery and surgical approach did not improve the complication rate. Perioperative morbidity has a significant impact on patient survival. The association be...
This study aimed to develop an artificial intelligence-based computer-aided diagnosis system (AI-CAD) emulating the diagnostic logic of radiologists for lymph node metastasis (LNM) in esophageal squam...
A total of 689 ESCC patients with PET/CT images were enrolled from three hospitals and divided into a training cohort and two external validation cohorts. 452 CT images from three publicly available d...
The AI-CAD achieved an accuracy of 0.744 for predicting pathological LNM in the external cohort and a good agreement with a human expert in two external validation cohorts (kappa = 0.674 and 0.587,...
The AI-CAD could aid in preoperative diagnosis of LNM in ESCC patients and thereby support clinical treatment decision-making....
We determined the usefulness of the estimation of physiologic ability and surgical stress (E-PASS), initially reported as a predictive factor for postoperative morbidity and mortality, as a prognostic...
Overall, 739 patients who underwent proctocolectomy for CRC at Tottori University Hospital and affiliated hospitals and histologically diagnosed with stage II CRC were included in the current study....
A receiver operating characteristic (ROC) analysis of the five-year recurrence-free survival indicated that the comprehensive risk score (CRS) of E-PASS predicted postoperative recurrence. A multivari...
The CRS predicts postoperative recurrence in patients with stage II CRC....
The 31-gene expression profile test (Class 1A: low-risk; 1B/2A: intermediate-risk; 2B: high-risk) is validated to identify patients with cutaneous melanoma who can safely forego sentinel lymph node bi...
Patients with T1-T2 tumors eligible for SLNB were seen by surgical oncologists (89.1%), dermatologists (7.8%), and medical oncologists (3.1%). After receiving 31-GEP results but before SLNB, clinician...
One hundred clinical decisions (52.4%) were influenced by the 31-GEP to forego SLNB and 70% (70/100) were not performed. Of the 30 performed, 0% (0/30) were positive. The 31-GEP influenced sixty-three...
In this prospective, multicenter study, clinicians demonstrated clinically meaningful use of the 31-GEP test to forego or pursue SLNB in patients with T1-T2 tumors resulting in a significant, risk app...
High grade, non-muscle invasive bladder cancer (NMIBC) is usually treated with intravesical Bacillus Calmette-Guérin. Chemohyperthermia therapy (CHT) may be a novel alternative therapy for the treatme...
To evaluate the recurrence-free survival (RFS) of patients treated with CHT using the Combat bladder recirculation system (BRS) for NMIBC....
This was a prospective multi-institutional study of 1,028 consecutive patients with NMIBC undergoing CHT between 2012 and 2020. A total of 835 patients were treated with CHT with Mitomycin C (MMC). Di...
Median follow up was 22.4 months (Interquartile range (IQR): 12.8 -35.8). Median age was 70.4 years (IQR: 62.1 -78.6). A total of 557 (66.7%), 172 (20.6) and 74 (8.9%) of patients were classified to B...
CHT with MMC using the Combat BRS is effective in the medium term and has a favorable adverse event profile....
Robotic Roux-en-Y gastric bypass (RRYGB) is performed in an increasing number of bariatric centers worldwide. Previous studies have identified a number of demographic and clinical variables as predict...
A retrospective analysis of two prospective databases containing patients who underwent RRYGB between 2006 and 2019 at two high volumes, accredited bariatric centers was performed. Primary outcome was...
Data of 1276 patients were analyzed, including 958 female and 318 male patients. Rates of overall and severe 30 day complications were 12.5% (160/1276) and 3.9% (50/1276), respectively. Rate of 30 day...
This study identified male sex and ASA score >2 as independent predictors of early postoperative complications after RRYGB. These data suggest a potentially different risk profile in terms of early po...
The COVID-19 outbreak disrupted medical access for patients receiving chronic opioid therapy. This study investigated their prescription opioid dosages before and after the 2020 outbreak in Taiwan....
A prospective questionnaire survey was conducted among registered outpatients receiving long-term opioids before July 2019 in Taiwan. The questionnaire included items from the Taiwanese Brief Pain Inv...
After a mean of 531 days, the questionnaire responses of 103 of the initial 117 respondents were reviewed. Daily opioid doses decreased for 31 respondents (30.1%), remained roughly equivalent (defined...
The COVID-19 outbreak in 2020 did not interrupt access to long-term opioid prescriptions for most registered patients with chronic pain in Taiwan. Less fentanyl patch use was observed in participants ...